GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kimia Biosciences Ltd (BOM:530313) » Definitions » EPS (Diluted)

Kimia Biosciences (BOM:530313) EPS (Diluted) : ₹ (TTM As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Kimia Biosciences EPS (Diluted)?

Kimia Biosciences's Earnings per Share (Diluted) for the six months ended in . 20 was ₹0.00.

Kimia Biosciences's EPS (Basic) for the six months ended in . 20 was ₹0.00.

Kimia Biosciences's EPS without NRI for the six months ended in . 20 was ₹0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Kimia Biosciences EPS (Diluted) Historical Data

The historical data trend for Kimia Biosciences's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kimia Biosciences EPS (Diluted) Chart

Kimia Biosciences Annual Data
Trend
EPS (Diluted)

Kimia Biosciences Semi-Annual Data
EPS (Diluted)

Competitive Comparison of Kimia Biosciences's EPS (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Kimia Biosciences's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kimia Biosciences's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kimia Biosciences's PE Ratio distribution charts can be found below:

* The bar in red indicates where Kimia Biosciences's PE Ratio falls into.



Kimia Biosciences EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Kimia Biosciences's Diluted EPS for the fiscal year that ended in . 20 is calculated as

Diluted EPS (A: . 20 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-)/0
=

Kimia Biosciences's Diluted EPS for the quarter that ended in . 20 is calculated as



Kimia Biosciences  (BOM:530313) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Kimia Biosciences EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Kimia Biosciences's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Kimia Biosciences (BOM:530313) Business Description

Traded in Other Exchanges
N/A
Address
Netaji Subhash Place, 974, 9th Floor, Aggarwal Millenium Tower-II, Pitampura, New Delhi, IND, 110 034
Kimia Biosciences Ltd is a company engaged in the manufacturing of bulk drugs. Some of the company's products include Azelnidipine, Deflazacort, Oxaceprol, Seratodast, and Tretinoin among others. Its only operating segment being Pharmaceuticals.

Kimia Biosciences (BOM:530313) Headlines

No Headlines